drugset / Trial / NCT01004042
Quality of Life and Self-esteem After Botox® Injections in Depressed and Non-depressed Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to determine the alterations in quality of life and self-esteem after BOTOX® injections in the glabella in depressed and non-depressed patients. The secondary objective of this study are: * to assess wrinkles improvement * to evaluate depressive symptoms using Beck Depression Inventory before and after Botox® injections. * to elucidate that depression is not a contraindication for botulinum toxin injections.
Timeline
- Start
- 2009-10
- Primary completion
- 2010-03
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 20 iu | — |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 40 iu | — |